A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer. (TARGIT-B)
An International Randomised Controlled Trial to Compare Targeted Intra-operative Radiotherapy Boost With Conventional External Beam Radiotherapy Boost After Lumpectomy for Breast Cancer in Women With a High Risk of Local Recurrence.
Sponsor: National Institute for Health Research, United Kingdom
A NA clinical study on Early Breast Cancer, this trial is ongoing. The trial is conducted by National Institute for Health Research, United Kingdom and has accumulated 9 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Sep 2024 — Sep 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
May 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — May 2022 [monthly]
Recruiting NA
▶ Show 4 earlier versions
-
Aug 2019 — Jan 2021 [monthly]
Recruiting NA
-
Mar 2019 — Aug 2019 [monthly]
Recruiting NA
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute for Health Research, United Kingdom
- University College, London
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aviano, Italy , Bangkok, Thailand , Barcelona, Spain , Beijing, China , Bordeaux, France , Caen, France , Cleveland, United States , Dammam, Saudi Arabia , Detroit, United States , Dijon, France and 20 more locations